Related Experiment Video
Updated: Jan 20, 2026
06:38
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
Published on: November 8, 2011
41.2K
Latency and lytic replication in Epstein-Barr virus-associated oncogenesis
1Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland. christian.muenz@uzh.ch.
Nature Reviews. Microbiology
|September 4, 2019
Summary
Epstein-Barr virus (EBV) oncogenes and lytic replication play complex roles in persistence and cancer. Novel immunotherapies may target EBV early lytic antigens and attenuated viruses.
Area of Science:
- Virology
- Oncology
- Immunology
Background:
- Epstein-Barr virus (EBV) is the first identified human tumor virus, linked to lymphomas and epithelial cancers.
- Traditionally, latent EBV proteins were considered oncogenic drivers, while lytic replication was thought to inhibit tumors.
- Recent findings challenge these established roles in EBV-driven tumorigenesis.
Purpose of the Study:
- To review recent evidence on the roles of EBV-encoded oncogenes, lytic replication, and non-coding RNAs in viral persistence and tumor formation.
- To discuss the evolving understanding of EBV's contribution to human malignancies.
- To explore potential therapeutic strategies based on these updated insights.
Main Methods:
- Review of current scientific literature and recent findings on Epstein-Barr virus.
- Analysis of the functions of latent and lytic EBV proteins in cellular transformation and virus maintenance.
- Evaluation of the role of EBV-encoded non-coding RNAs, particularly in immune evasion.
Main Results:
- Cellular transformation is not essential for EBV maintenance, contrary to previous assumptions.
- Initiation of the EBV lytic cycle actively supports EBV-driven malignancies, not just cell destruction.
- EBV non-coding RNAs primarily contribute to immune escape rather than direct cellular transformation.
Conclusions:
- The roles of EBV latent and lytic proteins in cancer development are more complex than previously understood.
- EBV non-coding RNAs are key mediators of immune evasion in virus-driven cancers.
- Targeting early lytic EBV antigens and attenuated viruses lacking oncogenes/microRNAs offers promising avenues for immunotherapy and vaccination.
Related Concept Videos
06:38Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
41.2K
We describe a method for generating transformed B cell lines using Epstein-Barr virus. We also illustrate a novel assay that can identify B cells destined to undergo transformation as early as three days after...
41.2K
09:14Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
4.6K
This protocol permits the isolation of Epstein-Barr virus particles from the human P3HR1 cell line upon inducing the viral lytic cycle with phorbol 12-myristate 13-acetate. DNA is subsequently extracted from the viral preparation and subjected to real-time PCR to quantify the viral particle concentration.
4.6K
11:28Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
11.5K
We describe a protocol to identify key roles of host signaling molecules in lytic replication of a model herpesvirus, gamma herpesvirus 68 (γHV68). Utilizing genetically modified mouse strains and embryonic fibroblasts for γHV68 lytic replication, the protocol permits both phenotypic characterization and molecular interrogation of virus-host interactions in viral lytic...
11.5K
07:10Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
806
This protocol describes an in vitro system to model de novo lytic infection of Kaposi's sarcoma-associated herpesvirus using BAC16-derived virions. The method enables investigation of early viral replication and dissemination. Infectious virus production is quantified by GFP-based infectious units assays and real-time PCR of encapsidated viral...
806
01:20Viral Replication: Lytic Cycle
1.3K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1.3K
01:30Lytic Cycle of Bacteriophages
77.5K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.5K